| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |